Viatris Drug For Further Processing
NDC Database

Viatris Drug For Further Processing

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 4
  • Latest Marketing Date 2025-10-28
  • Data Source FDA
  • First Marketing Date 2014-07-03
All
41
View
Bulk Ingredient
37
View
Drug for Further Processing
4
View
Company Overview

Company

Viatris Drug For Further Processing

Country

U.S.A

Website

Visit Website

Email

HRServiceCenter@Viatris.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Viatris Drug For Further Processing

Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317

U.S.A

www.viatris.com/en HRServiceCenter@Viatris.com View on Map
NDC Records ( 4 records )
2014
03 Jul
Drug for Further Processing NDC: 65427-012

Nonproprietary Name

Doxazosin mesylate

Dosage Form

TABLET, MULTILAYER, EXTENDED RELEASE

Strength

4 mg/1

Labeler

Viatris Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-012

Substance

DOXAZOSIN MESYLATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2014-07-03

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2014
03 Jul
Drug for Further Processing NDC: 65427-016

Nonproprietary Name

Doxazosin mesylate

Dosage Form

TABLET, MULTILAYER, EXTENDED RELEASE

Strength

8 mg/1

Labeler

Viatris Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-016

Substance

DOXAZOSIN MESYLATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2014-07-03

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
28 Oct
Drug for Further Processing NDC: 65427-300

Nonproprietary Name

prazosin hydrochloride

Dosage Form

TABLET

Strength

2.5 mg/1

Labeler

Viatris Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-300

Substance

PRAZOSIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-10-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
28 Oct
Drug for Further Processing NDC: 65427-301

Nonproprietary Name

prazosin hydrochloride

Dosage Form

TABLET

Strength

5 mg/1

Labeler

Viatris Pharmaceuticals LLC

Marketing Category

EXPORT ONLY

65427-301

Substance

PRAZOSIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-10-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    55 View
  • EDQM CEP
    31 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    41 View
  • FDA Approved Drugs Database
    922 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
4 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

65427-012

Nonproprietary Name

Doxazosin mesylate

Labeler

Viatris Pharmaceuticals LLC

Dosage Form

TABLET, MULTILAYER, EXTENDED RELEASE

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit